» Articles » PMID: 24549785

Activated Macrophages Promote Wnt/β-catenin Signaling in Cholangiocarcinoma Cells

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Feb 20
PMID 24549785
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The Wnt/β-catenin signaling pathway is pathologically activated in cholangiocarcinoma (CCA). Here, we determined the expression profile as well as biological role of activated Wnt/β-catenin signaling in CCA. The quantitative reverse transcription polymerase chain reaction demonstrated that Wnt3a, Wnt5a, and Wnt7b mRNA were significantly higher in CCA tissues than adjacent non-tumor tissues and normal liver tissues. Immunohistochemical staining revealed that Wnt3a, Wnt5a, and Wnt7b were positive in 92.1, 76.3, and 100 % of 38 CCA tissues studied. It was noted that Wnt3 had a low expression in tumor cells, whereas a high expression was mainly found in inflammatory cells. Interestingly, a high expression level of Wnt5a was significantly correlated to poor survival of CCA patients (P=0.009). Membrane localization of β-catenin was reduced in the tumors compared to normal bile duct epithelia, and we also found that 73.7 % of CCA cases showed the cytoplasmic localization. Inflammation is known to be a risk factor for CCA development, and we tested whether this might induce Wnt/β-catenin signaling. We found that lipopolysaccharides (LPS) elevated the expression of Wnt3 both mRNA and protein levels in the macrophage cell line. Additionally, the conditioned media taken from LPS-induced activated macrophage culture promoted β-catenin accumulation in CCA cells. Furthermore, transient suppression of β-catenin by siRNA significantly induced growth inhibition of CCA cells, concurrently with decreasing cyclin D1 protein level. In conclusion, the present study reports the abundant expression of Wnt protein family and β-catenin in CCA as well as the effect of inflammatory condition on Wnt/β-catenin activation in CCA cells. Importantly, abrogation of β-catenin expression caused significant CCA cell growth inhibition. Thus, the Wnt/β-catenin signaling pathway may contribute to CCA cell proliferation and hence may serve as a prognostic marker for CCA progression and provide a potential target for CCA therapy.

Citing Articles

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023).

Qu X, Wang Q, Zhu F, Liang H, Long Z, Wu Y Front Immunol. 2024; 15:1436315.

PMID: 39660136 PMC: 11628549. DOI: 10.3389/fimmu.2024.1436315.


Multi-Omics Profiling Unveils the Complexity and Dynamics of Immune Infiltrates in Intrahepatic Cholangiocarcinoma.

Li X, Wang Y, Guan R, Sheng N, Zhang S Biology (Basel). 2024; 13(10).

PMID: 39452125 PMC: 11504529. DOI: 10.3390/biology13100816.


Tumor microenvironment and immunology of cholangiocarcinoma.

Cadamuro M, Fabris L, Zhang X, Strazzabosco M Hepatoma Res. 2024; 8.

PMID: 39301518 PMC: 11412615. DOI: 10.20517/2394-5079.2021.140.


Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects.

Wang J, Liu S, Cao Y, Chen Y Front Cell Dev Biol. 2024; 12:1408852.

PMID: 39156971 PMC: 11327014. DOI: 10.3389/fcell.2024.1408852.


Signaling pathways in liver cancer: pathogenesis and targeted therapy.

Xue Y, Ruan Y, Wang Y, Xiao P, Xu J Mol Biomed. 2024; 5(1):20.

PMID: 38816668 PMC: 11139849. DOI: 10.1186/s43556-024-00184-0.


References
1.
Anson M, Crain-Denoyelle A, Baud V, Chereau F, Gougelet A, Terris B . Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest. 2012; 122(2):586-99. PMC: 3266772. DOI: 10.1172/JCI43937. View

2.
Lim K, Han C, Xu L, Isse K, Demetris A, Wu T . Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res. 2008; 68(2):553-60. DOI: 10.1158/0008-5472.CAN-07-2295. View

3.
Shen D, Zhang W, Zeng X, Liu C . Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma. Cancer Sci. 2013; 104(10):1303-8. PMC: 7656555. DOI: 10.1111/cas.12223. View

4.
Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W . Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene. 2010; 29(14):2036-46. DOI: 10.1038/onc.2009.496. View

5.
Taguchi K, Aishima S, Tanaka S, Shimada M, Kajiyama K, Sugimachi K . Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol. 2001; 14(9):900-5. DOI: 10.1038/modpathol.3880409. View